Evidence map›Paper›PMID 34619074›Full record

ReviewCell metabolism2021

Molecular aspects of fructose metabolism and metabolic disease.

Mark A Herman, Morris J Birnbaum

Registry-linked trialAbstract readReview
In one paragraph

Review in Cell metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06671756 (The Metabolic Response to Fructose Ingestion), which is not on this map. Cited by 155 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06671756 nacompletednot on this mapstarted 2024, after this paper: background citation

The Metabolic Response to Fructose Ingestion

TypeinterventionalSponsorBaylor College of MedicineRan2024 to 2025Enrolled8ConditionsHealthyArmsFructose Ingestion, Glucose Ingestion
3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark A HermanDivision of Endocrinology, Metabolism, and Nutrition, Duke University, Durham, NC, USA; Duke Molecular Physiology Institute, Duke University, Durham, NC, USA; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. Electronic address: mark.herman@duke.edu.
Morris J BirnbaumInternal Medicine Research Unit, Pfizer, Cambridge, MA, USA. Electronic address: morris.birnbaum@pfizer.com.

Funding

The Role of ChREBP in Fructose Induced Metabolic DiseaseR01DK100425 · NIDDK · DUKE UNIVERSITY · PI HERMAN, MARK A · 2014 to 2023
$3.6M
Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic diseaseR01DK121710 · NIDDK · DUKE UNIVERSITY · PI HERMAN, MARK A, NEWGARD, CHRISTOPHER B · 2019 to 2022
$2.7M
American Heart Association-American Stroke Association 16CSA28590003-HERMANNIDDK NIH HHS R01 DK100425NIDDK NIH HHS R01 DK121710
6 · The paper itself

Abstract

Excessive sugar consumption is increasingly considered as a contributor to the emerging epidemics of obesity and the associated cardiometabolic disease. Sugar is added to the diet in the form of sucrose or high-fructose corn syrup, both of which comprise nearly equal amounts of glucose and fructose. The unique aspects of fructose metabolism and properties of fructose-derived metabolites allow for fructose to serve as a physiological signal of normal dietary sugar consumption. However, when fructose is consumed in excess, these unique properties may contribute to the pathogenesis of cardiometabolic disease. Here, we review the biochemistry, genetics, and physiology of fructose metabolism and consider mechanisms by which excessive fructose consumption may contribute to metabolic disease. Lastly, we consider new therapeutic options for the treatment of metabolic disease based upon this knowledge.

Indexed as

FructoseMetabolic DiseasesDietGlucoseHumansLiverObesityFructoseGlucoseALDOBcardiometabolic diseaseChREBPfructoseGLUT5insulin resistanceKHKlipogenesisNAFLDsteatosisTKFCuric acid

Identifiers

PMID34619074
PMCPMC8665132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.